Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

EN-3247 fails to prevent oral mucositis in pivotal trial

Oct. 29, 2003

Bay-43-9006 enters pivotal phase III trial in kidney cancer

Oct. 29, 2003

Yamanouchi describes new antitumor agents from Pseudomonas species

Oct. 29, 2003

Novel HDAC inhibitors isolated from a marine sponge by Yamanouchi scientists

Oct. 29, 2003

Steryl sulfatase inhibitors identified by Kyowa Hakko researchers

Oct. 29, 2003

Synthetic discorhabdin analogues and intermediates covered by Sankyo patent

Oct. 29, 2003

Improved tear production on topical ciclosporin in Sjogren's syndrome

Oct. 29, 2003

A novel therapeutic role suggested for vitamin D analogues in breast cancer

Oct. 29, 2003

Evotec and Roche enter medicinal chemistry collaboration in oncology

Oct. 29, 2003

Neose to develop glycoPEGylated G-CSF

Oct. 29, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
Jiangsu Nhwa Pharmaceutical patents new κ-opioid receptor antagonists
BioWorld Science
Jiangsu Nhwa Pharmaceutical Co. Ltd. has disclosed κ-opioid receptor antagonists that are potentially useful for the treatment of neurological disorders.